MEDIGENE
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | MDG1 |
| ISIN: | DE000A1X3W00 |
MEDIGENE news, videos and press releases
For more news please use our advanced search feature.
MEDIGENE - More news...
MEDIGENE - More news...
- 03/13/2025 - 13:30 Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
- 02/27/2025 - 08:00 Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers
- 02/19/2025 - 10:00 Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
- 02/03/2025 - 17:00 Medigene AG announces closing of its first SEPA tranche
- 12/09/2024 - 10:00 Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
- 12/03/2024 - 10:00 Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
- 11/26/2024 - 13:00 Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
- 11/12/2024 - 12:00 Medigene Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024
- 11/11/2024 - 12:00 Medigene Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024
- 11/08/2024 - 14:30 Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024
- 10/29/2024 - 10:30 Medigene to Present at Upcoming Investor Conferences
- 10/24/2024 - 05:30 Medigene AG reports Financial Results and Business Update for Q3 2024
- 10/17/2024 - 09:30 Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024
- 10/16/2024 - 09:30 Medigene to Present at Upcoming Scientific Conferences
- 10/02/2024 - 13:00 Medigene will Present at ASGCT 2024 and Host R&D Event
- 09/25/2024 - 07:00 Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
- 09/16/2024 - 12:30 Medigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
- 09/14/2024 - 11:30 Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
- 09/05/2024 - 12:00 Medigene Announces U.S. FDA Clearance of IND Application for MDG1015, a First-in-Class, Third Generation T Cell Receptor Engineered T Cell (TCR-T) Therapy for Multiple Solid Tumor Indications
- 03/10/2020 - 21:06 Phio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with Medigene
